We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

169 hedge funds and large institutions have $282M invested in Spectrum Pharmaceuticals Inc in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 51 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 21

1% more funds holding

Funds holding: 167169 (+2)

2% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 51

8% less call options, than puts

Call options by funds: $5.65M | Put options by funds: $6.12M

60% less capital invested

Capital invested by funds: $708M → $282M (-$426M)

Holders
169
Holders Change
+2
Holders Change %
+1.2%
% of All Funds
3.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
29
Increased
52
Reduced
51
Closed
21
Calls
$5.65M
Puts
$6.12M
Net Calls
-$470K
Net Calls Change
+$9.68M
Name Holding Trade Value Shares
Change
Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$1.1M +$2.44M +301,874 New
PAM
27
Panagora Asset Management
Massachusetts
$1.04M -$1.73M -213,745 -43%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$935K +$280K +34,700 +16%
Public Sector Pension Investment Board (PSP Investments)
29
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$921K -$270K -33,400 -12%
Bank of America
30
Bank of America
North Carolina
$885K -$580K -71,790 -23%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$827K +$1.84M +227,308 New
SIG
32
Sargent Investment Group
Maryland
$764K -$2.63M -325,475 -61%
QI
33
QS Investors
New York
$753K -$10.9K -1,350 -0.6%
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$738K -$44.6K -5,525 -3%
Prudential Financial
35
Prudential Financial
New Jersey
$716K -$151K -18,750 -9%
Swiss National Bank
36
Swiss National Bank
Switzerland
$708K +$42.8K +5,300 +3%
Russell Investments Group
37
Russell Investments Group
United Kingdom
$707K +$276K +34,114 +21%
AllianceBernstein
38
AllianceBernstein
Tennessee
$641K +$5.66K +700 +0.4%
Barclays
39
Barclays
United Kingdom
$622K -$572K -70,846 -29%
JP Morgan Chase
40
JP Morgan Chase
New York
$619K -$30.8K -3,814 -2%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$617K -$45.3K -5,606 -3%
AGM
42
Alpine Global Management
New York
$614K +$1.36M +168,692 New
State of Wisconsin Investment Board
43
State of Wisconsin Investment Board
Wisconsin
$609K
Deutsche Bank
44
Deutsche Bank
Germany
$595K -$557K -68,940 -30%
Group One Trading
45
Group One Trading
Illinois
$590K +$1.13M +139,764 +624%
PPA
46
Parametric Portfolio Associates
Washington
$576K -$41.4K -5,124 -3%
PP
47
PDT Partners
New York
$517K +$223K +27,541 +24%
New York State Teachers Retirement System (NYSTRS)
48
New York State Teachers Retirement System (NYSTRS)
New York
$514K
Canada Life
49
Canada Life
Manitoba, Canada
$503K +$1.13M +139,638 New
Fisher Asset Management
50
Fisher Asset Management
Washington
$477K -$568K -70,260 -35%

SPPI Hedge Fund Activity: Q4 2019 in Review

169 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2019, worth a combined $282M — down 60% from $708M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SPPI positions and 21 closed out — a net gain of 8 holders — while 52 added to existing stakes and 51 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $9.99M. The largest seller was Primecap Management, cutting an estimated $36.8M.

  • 169 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2019, up from 167 in Q3 2019.
  • Funds reported $282M of Spectrum Pharmaceuticals Inc stock for Q4 2019, down 60% quarter-over-quarter.
  • 29 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2019 and 21 closed out, a net change of +8 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q4 2019 was Wellington Management Group, an estimated $9.99M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q4 2019 was Primecap Management, an estimated $36.8M sold.

Based on aggregated 13F filings for Q4 2019.